67 Results for "

RIP kinase

" in MedChemExpress (MCE) Product Catalog:
Products (67)

67 Results for "RIP kinase" in MCE Product Catalog:

561
561 Publications Verification
Cat. No.: HY-15760
CAS No.: 4311-88-0
Purity:  99.89%
Synonyms: Nec-1
Necrostatin-1 (Nec-1) is a potent and cross the blood-brain barrier necroptosis inhibitor with an EC50 of 490 nM in Jurkat cells. Necrostatin-1 inhibits RIP1 kinase (EC50=182 nM). Necrostatin-1 is also an IDO inhibitor .
loading...
    loading...
110
110 Cited Publications
Cat. No.: HY-101872
CAS No.: 1346546-69-7
Purity:  99.80%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK-872 is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM. GSK-872 decreases the RIPK3-mediated necroptosis and subsequent cytoplasmic translocation and expression of HMGB1, as well as ameliorates brain edema and neurological deficits in early brain injury .
loading...
    loading...
110
110 Cited Publications
Cat. No.: HY-101872A
CAS No.: 2703752-81-0
Purity:  99.21%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK-872 hydrochloride is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM. GSK-872 hydrochloride decreases the RIPK3-mediated necroptosis and subsequent cytoplasmic translocation and expression of HMGB1, as well as ameliorates brain edema and neurological deficits in early brain injury .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-100339
CAS No.: 1346547-00-9
Purity:  99.93%
Target:  

RIP kinase

Research Areas:  

Endocrinology

GSK583 is a highly potent, orally active and selective inhibitor of RIP2 Kinase, with IC50 of 5 nM. GSK583 inhibits both TNF-α and IL-6 production with an IC50 value of 200 nM.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-101760
CAS No.: 1622848-92-3
Purity:  99.79%
GSK2982772 is a potent, orally active and ATP competitive RIP1 kinase inhibitor with IC50 values of 16 nM and 20 nM for human and monkey RIP1, respectively .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-125402
CAS No.: 1601496-05-2
Purity:  99.18%
Synonyms: GSK'843
Target:  

RIP kinase Apoptosis

Research Areas:  

Inflammation/Immunology

GSK-843 (GSK'843) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 8.6 nM, and inhibits kinase activity with an IC50 of 6.5 nM. GSK-843 can be used for the research of inflammation .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114349
CAS No.: 2158197-70-5
Purity:  99.89%
Target:  

RIP kinase

Research Areas:  

Cardiovascular Disease Cancer

HS-1371 is a potent and ATP-competitive receptor-interacting protein kinase 3 (RIP3) inhibitor with an IC50 of 20.8 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0339
CAS No.: 125-33-7
Primidone is the orally active inhibitor for TRPM3 (IC50 = 0.6 μM), RIP kinase and voltage-gated sodium channel, and the antagonist for GABA receptor. Primidone can be used as the analgesic and anticonvulsant agent .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N2166
CAS No.: 17406-45-0
Synonyms: α-Tomatine; Lycopersicin; Tomatin
Tomatine is a glycoalkaloid, found in the tomato plant (Lycopersicon esculentum Mill.). Tomatine elicits neurotoxicity in RIP1 kinase and caspase-independent manner. Tomatine promotes the upregulation of nuclear apoptosis inducing factor (AIF) in neuroblastoma cells. Tomatine also inhibits 20S proteasome activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-112038A
Purity:  98.82%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK2983559 is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-112038
CAS No.: 1579965-12-0
Purity:  99.90%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK2983559 free acid (compound 3) is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 free acid can block many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19761
CAS No.: 1581270-11-2
Target:  

RIP kinase

Research Areas:  

Cancer

RIP2 kinase inhibitor 2 is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043437 A1, compound example 9.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103028A
CAS No.: 2049868-46-2
Purity:  99.10%
Target:  

RIP kinase

Research Areas:  

Others

GSK963 is a chiral, highly potent and selective inhibitor of RIP1 kinase, with an IC50 of 29 nM. GSK963 is a selective and potent inhibitor of necroptosis in murine and human cells in vitro .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-104021
CAS No.: 2361146-30-5
Purity:  99.95%
Synonyms: GSK'840
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK840 (GSK'840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 0.9 nM, and inhibits kinase activity with an IC50 of 0.3 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111946
CAS No.: 1622849-43-7
Purity:  99.39%
Target:  

RIP kinase

Research Areas:  

Cancer

GSK3145095 is a RIP1 kinase inhibitor with an IC50 of 6.3 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100131
CAS No.: 1622849-58-4
Purity:  98.57%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK481 is a highly potent, selective, and specific receptor interacting protein 1 (RIP1) kinase inhibitor with an IC50 of 1.3 nM, which inhibits Ser 166 phosphorylation in wild-type human RIP1 (IC50=2.8 nM). GSK481 also exhibits excellent translation in the U937 cellular assay with an IC50 of 10 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19764
CAS No.: 1423186-80-4
Target:  

RIP kinase

Research Areas:  

Cancer

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
loading...
    loading...
Cat. No.: HY-152846
CAS No.: 2268739-68-8
Synonyms: GDC-8264
Flizasertib (GDC-8264) is an orally active, reversible and selective RIP1 inhibitor with Ki app values of 0.00071 μM and 0.0013 μM for human and cynomolgus monkey RIP1 kinase, respectively. Flizasertib blocks RIP1 autophosphorylation but does not affect RIP1 protein stability. Flizasertib inhibits pro-inflammatory cytokines (CCL3, CCL4, and IL-1β) production. Flizasertib results in inhibition of colitis and ileitis. Flizasertib can be used in the research of cardiac surgery-associated acute kidney injury .
loading...
    loading...
Cat. No.: HY-111409
CAS No.: 2095515-38-9
Purity:  99.96%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIP1 kinase inhibitor 1 (compound 22) is a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor (pKi=9.04) .
loading...
    loading...
Cat. No.: HY-18901
CAS No.: 1481641-08-0
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIPK1-IN-4 (compound 8) is a potent and selective type II kinase inhibitor of receptor interacting protein 1 (RIP1) kinase and binds to a DLG-out inactive form of RIP1 with an IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase .
loading...
    loading...